Deep TMS News - Get The Latest News On BrainsWay's Deep TMS

News & Events

March 28, 2024

BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis

Data Published in Leading Peer-Reviewed Publication, Journal of Clinical Medicine JERUSALEM and BURLINGTON,...

March 18, 2024

BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems

Katie’s Way Provides Lifesaving Mental Health Treatment Nationally with a Focus on Servicemembers,...

March 6, 2024

BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights

Generated Record Revenues with Robust 50% Year-over-Year Revenue Growth in Q4 2023; Generated Positive...

February 21, 2024

BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

BURLINGTON, Mass. and JERUSALEM, Israel, February 21, 2024 – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

January 10, 2024

BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology

BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...

December 19, 2023

BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network

BURLINGTON, Mass. and JERUSALEM, Dec. 19, 2023 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...

December 7, 2023

BrainsWay Announces Continued Expansion of Deep TMS™ in South Korea

BURLINGTON, Mass. and JERUSALEM, December X, 2023 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

November 20, 2023

Louisiana Insurer Expands Deep TMS™ Access for 1.9 Million Covered Lives

BURLINGTON, Mass. and JERUSALEM, November 20, 2023 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

November 15, 2023

BrainsWay Reports Third Quarter 2023 Financial Results and Operational Highlights

Generated Robust 61% Year-over-Year Revenue Growth in Q3 2023 Nearing Breakeven Operating Income, Achieved...

November 2, 2023

Clinical TMS Society Publishes First Coverage Recommendations for the Treatment of Smoking Addiction

BrainsWay Deep TMS™ is the Only TMS System FDA-Cleared to Treat Smoking Addiction   BURLINGTON,...

November 1, 2023

BrainsWay to Report Third Quarter 2023 Financial Results on November 15, 2023

BURLINGTON, Mass. and JERUSALEM, Nov. 01, 2023 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...

October 16, 2023

BrainsWay Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Depression

Peer-reviewed Results Suggest Accelerated Deep TMS Outcomes Comparable to Standard Treatment Protocols BURLINGTON,...

September 27, 2023

BrainsWay Announces Presentation of Two Deep TMS™ Posters at Upcoming World Congress of Psychiatry

Preliminary Research on Late Life Depression and Accelerated Depression Treatment Protocol will be Featured BURLINGTON,...

September 20, 2023

BrainsWay Broadens Access to Deep TMS™ for U.S. Military Service Members Through Expanded Partnership with Katie’s Way Plus

Provider of Mental Health Services with Focus on Military Community Orders 10 New Deep TMS™ Systems...

September 5, 2023

BrainsWay Forges Strategic Partnership with Treatment Provider in Northeast U.S.

 10 Deep TMS™ Systems to be Installed in 2023 Alone  BURLINGTON, Mass. and JERUSALEM, September 5,...

August 23, 2023

BrainsWay Further Expands Access to Deep TMS™ in Asia Pacific Region

Multisystem Purchases by Unison Healthcare Group Increase Availability of Deep TMS™ in Taiwan BURLINGTON,...

August 9, 2023

BrainsWay Reports Second Quarter 2023 Financial Results and Operational Highlights

BURLINGTON, Mass. and JERUSALEM, August 9, 2023 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ &...

August 3, 2023

BrainsWay Announces Publication of Three New Deep TMS Research Publications

New Articles Enhance Understanding of Deep TMS Safety Profile and Survey Addiction Research BURLINGTON,...